Chemoradiotherapy and surgery for T4 esophageal cancer in Japan

被引：27

作者：

Akutsu, Yasunori ^{[1
]}

Matsubara, Hisahiro ^{[1
]}

机构：

[1] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Chiba 2608670, Japan

来源：

SURGERY TODAY | 2015年 / 45卷 / 11期

关键词：

Esophageal cancer; T4; Chemoradiotherapy; Surgery; Japan; SQUAMOUS-CELL CARCINOMA; DEFINITIVE CHEMORADIOTHERAPY; RADIATION-THERAPY; PREOPERATIVE CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; CISPLATIN; TRIAL; 5-FLUOROURACIL; DOCETAXEL;

D O I：

10.1007/s00595-015-1116-4

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Esophageal cancer is thought to be the most malignant neoplasm due to its biological aggressiveness. The most effective treatment modality for esophageal cancer, particularly T4 esophageal cancer, is chemoradiotherapy (CRT). Some T4 patients show long-term survival after receiving CRT, suggesting that even T4 esophageal cancer can be cured with this modality. Although surgery is performed after CRT in some T4 cases, its prognostic benefit is controversial. In this paper, we review the status of CRT and conversion surgery as well as the development of new regimens and discuss the future prospects of CRT in the treatment of T4 esophageal cancer in Japan.

引用

页码：1360 / 1365

页数：6

共 50 条

[21] Outcome of chemoradiotherapy followed by surgery for locally advanced T4 thoracic esophageal squamous cell carcinoma.
Akutsu, Yasunori
Kono, Tsuguaki
Uesato, Masaya
Hoshino, Isamu
Murakami, Kentaro
Matsubara, Hisahiro
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[22] SURGERY FOR T4 LUNG-CANCER - THE PROGNOSES OF T4 LUNG-CANCER
KIMURA, M
MIZUMOTO, T
NAMIKAWA, S
YADA, I
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1994, 24 (06) : 316 - 321
[23] Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy
Gao, Lin-Rui
Li, Chen
Han, Weiming
Ni, Wenjie
Deng, Wei
Tan, Lijun
Zhou, Zongmei
Chen, Dongfu
Feng, Qinfu
Liang, Jun
Lv, Jima
Wang, Wenqing
Liu, Wenyang
Deng, Lei
Wang, Xin
Zhang, Tao
Wang, Jianyang
Zhai, Yirui
Bi, Nan
Wang, Lvhua
Hui, Zhouguang
Li, Ye-Xiong
Xiao, Zefen
[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[24] Clinical characteristics of recurrent esophageal cancer after definitive chemoradiotherapy for stage II/III (non T4) esophageal squamous cell cancer
Nishikawa, Akiko
Kato, Ken
Honma, Yoshitaka
Iwasa, Satoru
Takashima, Atsuo
Hamaguchi, Tetsuya
Yamada, Yasuhida
Shimada, Yasuhiro
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[25] T4 esophageal cancer treated with radical resection
Zhong, Hai
Li, Qianjun
Gao, Wenhui
Li, Xiang
Zhang, Junhua
Wu, Xu
[J]. PANMINERVA MEDICA, 2019, 61 (04) : 509 - 511
[26] Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study
Hideaki Shimoji
Hiroyuki Karimata
Masayoshi Nagahama
Tadashi Nishimaki
[J]. World Journal of Surgery, 2013, 37 : 2180 - 2188
[27] Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study
Shimoji, Hideaki
Karimata, Hiroyuki
Nagahama, Masayoshi
Nishimaki, Tadashi
[J]. WORLD JOURNAL OF SURGERY, 2013, 37 (09) : 2180 - 2188
[28] The Ability of Surgery in T4 Lung Cancer
Sanli, Aydin
[J]. EUROPEAN JOURNAL OF THERAPEUTICS, 2018, 24 : S33 - S39
[29] Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer
Vellayappan, Balamurugan A.
Soon, Yu Yang
Ku, Geoffrey Y.
Leong, Cheng Nang
Lu, Jiade J.
Tey, Jeremy C. S.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
[30] Early tumor response to induction chemotherapy or chemoradiotherapy is a significant prognostic predictor in patients with initially unresectable T4 esophageal cancer following subsequent surgery
Shimoji, Hideaki
Karimata, Hiroyuki
Nishimaki, Tadashi
[J]. ESOPHAGUS, 2015, 12 (03) : 233 - 243

← 1 2 3 4 5 →